{"id":682,"date":"2020-09-29T21:27:19","date_gmt":"2020-09-29T21:27:19","guid":{"rendered":"https:\/\/www.amalgamatedbenefits.com\/amalgamated-medical-care-management\/?p=682"},"modified":"2022-08-04T17:05:52","modified_gmt":"2022-08-04T17:05:52","slug":"utilization-management-helps-self-funded-plans-contain-healthcare-costs","status":"publish","type":"post","link":"https:\/\/www.amalgamatedbenefits.com\/amalgamated-medical-care-management\/utilization-management-helps-self-funded-plans-contain-healthcare-costs\/","title":{"rendered":"Utilization Management Helps Self-funded Plans Contain Healthcare Costs"},"content":{"rendered":"\n
\"Two<\/figure>\n\n\n\n

From all projections, U.S. employers should expect their healthcare costs to rise in 2021.  Self-insured and fully-insured plans could see their premiums increase between 5-6% according to projections by the consulting firm of Willis Towers Watson.  Factors that will influence their premium increases include: the potential of new COVID-19 waves, the costs of a vaccine or therapeutic agents, and the effectiveness of policies deployed to mitigate the virus\u2019 spread.<\/p>\n\n\n\n

Self-funded plans could be especially hard hit by rising health care claims next year.  Willis Towers Watson projected that self-funded plans could incur a 7 percent increase in health care claims in 2021 if many of their workers are hospitalized with COVID-19.  There are options and tools that self-funded plan sponsors can use to help contain their healthcare costs in 2021.  It\u2019s important that plan sponsors carefully weigh their options and take advantage of proven cost-containment tools such utilization management.<\/p>\n\n\n\n

Options and Tools for Self-Funded Plans<\/h2>\n\n\n\n

For instance, self-funded plans can choose not to waive their members\u2019 cost-sharing for COVID-19 treatment inclusive of deductibles, co-insurance and co-pays for treating COVID-19. Electing to do so would be understandable given the severe economic impacts many businesses incurred as a result of mandated lockdowns. Weighing into their decision will be the costs associated with treating COVID-19. Willis Towers Watson\u2019s cost analysis provides a look at some of the costs associated with treating a COVID-19 patient. They include:<\/p>\n\n\n\n